BioCentury
ARTICLE | Company News

AMBI, University of North Carolina deal

January 2, 2001 8:00 AM UTC

AMBI obtained an option to exclusively license the university's U.S. Patents Nos. 5,972,390 and 6,034,125 covering the use of chromium as a nutritional supplement to treat depression and pre-menstrual...